Midwest Medical Care

Sioux Falls, South Dakota 57108

0 studies enrolling now · 5 studies all time

What they study most

Colitis, Ulcerative, Diarrhea Predominant Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed